Real-World Patient Experience of CGRP-Targeting Therapy for Migraine: a Narrative Review

被引:0
|
作者
Ann M. Murray
Jennifer I. Stern
Carrie E. Robertson
Chia-Chun Chiang
机构
[1] Mayo Clinic,Department of Neurology
来源
关键词
Real-world studies; CGRP; Monoclonal antibody; CGRP receptor antagonist; Medication overuse; Chronic migraine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:783 / 794
页数:11
相关论文
共 50 条
  • [1] Real-World Patient Experience of CGRP-Targeting Therapy for Migraine: a Narrative Review
    Murray, Ann M.
    Stern, Jennifer I.
    Robertson, Carrie E.
    Chiang, Chia-Chun
    CURRENT PAIN AND HEADACHE REPORTS, 2022, 26 (10) : 783 - 794
  • [2] CGRP-targeting antibodies reduce migraine frequency
    Heather Wood
    Nature Reviews Neurology, 2018, 14 : 63 - 63
  • [3] CGRP-targeting antibodies reduce migraine frequency
    Wood, Heather
    NATURE REVIEWS NEUROLOGY, 2018, 14 (02) : 62 - 62
  • [4] Real-World Experience with CGRP-antagonists in the Treatment of Migraine
    Bucklan, J. N.
    Lee, M.
    Patel, P.
    Shadbehr, N.
    Ahmed, Z.
    Kriegler, J. S.
    George, N.
    Hogue, O.
    Hardin, B.
    Deal, J.
    HEADACHE, 2019, 59 : 46 - 47
  • [5] CGRP Targeting Therapy for Chronic Migraine—Evidence from Clinical Trials and Real-world Studies
    Yen-Feng Wang
    Shuu-Jiun Wang
    Current Pain and Headache Reports, 2022, 26 : 543 - 554
  • [6] Long-Term Outcome After Discontinuation of CGRP-Targeting Therapy for Migraine
    Cho, Soohyun
    Kim, Byung-Kun
    CURRENT PAIN AND HEADACHE REPORTS, 2024, 28 (08) : 743 - 751
  • [7] CGRP Targeting Therapy for Chronic Migraine-Evidence from Clinical Trials and Real-world Studies
    Wang, Yen-Feng
    Wang, Shuu-Jiun
    CURRENT PAIN AND HEADACHE REPORTS, 2022, 26 (07) : 543 - 554
  • [8] CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
    Scheffler, Armin
    Schenk, Hannah
    Wurthmann, Sebastian
    Nsaka, Michael
    Kleinschnitz, Christoph
    Glas, Martin
    Holle, Dagny
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01):
  • [9] CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
    Armin Scheffler
    Hannah Schenk
    Sebastian Wurthmann
    Michael Nsaka
    Christoph Kleinschnitz
    Martin Glas
    Dagny Holle
    The Journal of Headache and Pain, 2021, 22
  • [10] MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment
    Ornello, Raffaele
    Zelli, Veronica
    Compagnoni, Chiara
    Caponnetto, Valeria
    De Matteis, Eleonora
    Tiseo, Cindy
    Tessitore, Alessandra
    Sacco, Simona
    JOURNAL OF HEADACHE AND PAIN, 2024, 25 (01):